APOE and Alzheimer disease: Interestingly, one case in the DS cohort displayed low levels of soluble Aβ species in the frontal cortex, consistent with the mild AD neuropathologic changes present at autopsy and in the context of an ApoE 2/3 genotype (Table 1, Figure 2).